Recursion Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discov…

Biotechnology
US, Salt Lake City [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of RXRX's Analysis
CIK: 1601830 CUSIP: 75629V104 ISIN: US75629V1044 LEI: - UEI: -
Secondary Listings
RXRX has no secondary listings inside our databases.